Blockchain Registration Transaction Record

Scinai's PC111 Research Wins Prestigious Dermatology Award

Scinai Immunotherapeutics celebrates Dr. Roberta Lotti's award for PC111 research, a breakthrough in treating pemphigus vulgaris, showcasing potential for non-immunosuppressive therapies.

This news is significant as it highlights a potential breakthrough in the treatment of pemphigus vulgaris, a painful and debilitating autoimmune skin disease. The recognition of PC111's research with the "Oscar of Italian Dermatology" underscores its innovative approach to blocking disease progression without suppressing the immune system, offering hope for safer and more effective treatments. For investors and the biotech community, Scinai's progress with PC111 and its strategic option to acquire Pincell Srl represents a noteworthy development in the biopharmaceutical sector, with implications for future therapies in immunology and inflammation.